It is 11:30 AM on a Wednesday. A clinician at a busy private hospital in Nairobi orders an urgent liver function test for a patient presenting with jaundice and suspected hepatotoxicity. The request reaches the lab. The lab tech checks the analyser. The reagents ran out four days ago.
The supplier? On credit hold. Invoices outstanding for seven months.
The patient waits. The clinician treats blind. Nobody in the finance office made that connection when they deprioritised the supplier payment in last month's cash flow review.
This is not a hypothetical. It is a pattern — quiet, systemic, and far more common than the Kenyan healthcare industry is willing to admit publicly.
The Invisible Link Between Payment Cycles and Clinical Outcomes
Healthcare finance teams operate in silos. Accounts payable is measured by cash conservation, budget adherence, and working capital ratios. It is rarely measured by its downstream impact on clinical operations. But in the diagnostics supply chain, that downstream impact is direct and consequential.
When a hospital delays payment to a medical supplies distributor long enough, a predictable sequence unfolds. First, the supplier tightens credit terms. Then, orders are fulfilled partially or on a pro-forma basis only. Then, supply continuity breaks. Reagents run short. Consumables are rationed. Preventive maintenance visits are quietly deferred. Emergency callouts get deprioritised. And somewhere at the end of that chain, a patient gets a delayed result, a deferred procedure, or a clinical decision made without adequate diagnostic information.
The finance team never sees that patient. But the connection is real.
The Numbers Kenya's Health Sector Needs to Confront
Days Sales Outstanding — the average number of days a supplier waits to be paid — runs between 120 and 300 days across much of Kenya's private healthcare sector. Some public facilities run even longer. For context, a distributor importing reagents from an OEM in Europe or China is typically operating on 30 to 60 day payment terms from their own suppliers. That gap — between what they owe and what they are owed — is carried entirely by working capital.
Working capital is not infinite. When it runs out, supply chains fracture. The facilities that pushed longest and hardest on payment terms are often the first to experience stock-outs, because they have exhausted the goodwill and the credit headroom of every supplier in their ecosystem.
What High-Performing Facilities Do Differently
The hospitals and clinics that maintain consistently excellent diagnostic operations share a common trait that has nothing to do with the brands of equipment they purchase. They pay on time — or they communicate early and honestly when they cannot.
That sounds simple. It changes everything.
A supplier that trusts a facility's payment integrity will extend emergency credit during a genuine cash crunch. They will prioritise that facility's deliveries when stock is constrained. They will send a service engineer on a Saturday morning because the relationship warrants it. They will offer better pricing over time, because the cost of financing a 200-day DSO is embedded in every quote to every client — and facilities that do not impose that cost do not bear it.
High-performing procurement teams also think in tiers. Not every payable line item carries the same clinical risk. Reagents and consumables for high-utilisation analysers are tier-one critical. Deferring payment on those is a clinical risk decision, not just a financial one — and it should be escalated accordingly.
A Reframe Worth Making
The CFO's office owns accounts payable. But the consequences of a broken diagnostics supply chain land in the clinical director's lap, in patient satisfaction scores, in accreditation audits, and in the quiet erosion of a facility's reputation for reliability.
Accounts receivable management in healthcare is a clinical governance issue wearing a finance uniform. The facilities that recognise this govern it accordingly — with cross-functional accountability, clear payment prioritisation frameworks, and supplier relationships built on integrity rather than leverage.
The ones that do not will continue to wonder why their labs keep running out of reagents.
Sam-Tech Diagnostics Co. Ltd partners with healthcare facilities across Kenya on transparent, reliability-first supply relationships. We believe that when suppliers and facilities operate with mutual accountability, patients are better served — every time.